Association of Adverse Effects of Medical Treatment With Mortality in the United States: A Secondary Analysis of the Global Burden of Diseases, Injuries, and Risk Factors Study.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
04 01 2019
04 01 2019
Historique:
entrez:
19
1
2019
pubmed:
19
1
2019
medline:
23
11
2019
Statut:
epublish
Résumé
More than 20 years have passed since the first publication of estimates of the extent of medical harm occurring in hospitals in the United States. Since then, considerable resources have been allocated to improve patient safety, yet policymakers lack a clear gauge of the progress made. To quantify the cause-specific mortality associated with adverse effects of medical treatment (AEMT) in the United States from 1990 to 2016 by age group, sex, and state of residence and to describe trends in types of harm and associations with other diseases and injuries. Cohort study using 1990-2016 data on mortality due to AEMT from the Global Burden of Diseases, Injuries, and Risk Factors (GBD) 2016 study, which assessed death certificates of US decedents. Death with International Classification of Diseases (ICD)-coded registration. Mortality associated with AEMT. Secondary analyses were performed on all ICD codes in the death certificate's causal chain to describe associations between AEMT and other diseases and injuries. From 1990 to 2016, there were an estimated 123 603 deaths (95% uncertainty interval [UI], 100 856-163 814 deaths) with AEMT as the underlying cause. Despite an overall increase in the number of deaths due to AEMT over time, the national age-standardized mortality rate due to AEMT decreased by 21.4% (95% UI, 1.3%-32.2%) from 1.46 (95% UI, 1.09-1.76) deaths per 100 000 population in 1990 to 1.15 (95% UI, 1.00-1.60) deaths per 100 000 population in 2016. Men and women had similar rates of AEMT mortality, and those 70 years or older had mortality rates nearly 20-fold greater compared with those aged 15 to 49 years (mortality rate in 2016 for both sexes, 7.93 [95% UI, 7.23-11.45] per 100 000 population for those aged ≥70 years vs 0.38 [95% UI, 0.34-0.43] per 100 000 population for those aged 15-49 years). Per 100 000 population, California had the lowest age-standardized AEMT mortality rate at 0.84 deaths (95% UI, 0.57-1.47 deaths), whereas Mississippi had the highest mortality rate at 1.67 deaths (95% UI, 1.19-2.03 deaths). Surgical and perioperative events were the most common subtype of AEMT, accounting for 63.6% of all deaths for which an AEMT was identified as the underlying cause. This study's findings suggest a modest reduction in the mortality rate associated with AEMT in the United States from 1990 to 2016 while also observing increased mortality associated with advancing age and noted geographic variability. The annual GBD releases may allow for tracking of the burden of AEMT in the United States.
Identifiants
pubmed: 30657530
pii: 2720915
doi: 10.1001/jamanetworkopen.2018.7041
pmc: PMC6484545
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e187041Références
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
J Patient Saf. 2016 Oct 20;:
pubmed: 27768654
J Patient Saf. 2016 Feb 6;:
pubmed: 26854418
JAMA. 2003 Mar 5;289(9):1107-16
pubmed: 12622580
Popul Health Metr. 2010 May 10;8:9
pubmed: 20459720
Behav Res Methods. 2015 Dec;47(4):1237-1259
pubmed: 25410404
Popul Health Metr. 2012 Jan 06;10:1
pubmed: 22226226
N Engl J Med. 1991 Feb 7;324(6):370-6
pubmed: 1987460
Qual Saf Health Care. 2009 Feb;18(1):5-10
pubmed: 19204125
JAMA. 2012 May 23;307(20):2155-6
pubmed: 22618920
BMJ Qual Saf. 2017 May;26(5):423-428
pubmed: 27733444
Med Care. 2000 Aug;38(8):868-76
pubmed: 10929998
N Engl J Med. 2010 Nov 25;363(22):2124-34
pubmed: 21105794
PLoS One. 2014 May 30;9(5):e97714
pubmed: 24878897
Health Serv Res. 2009 Apr;44(2 Pt 2):739-55
pubmed: 21456114
J Patient Saf. 2017 Oct 12;:
pubmed: 29023303
Health Serv Res. 2001 Dec;36(6 Pt 2):110-32
pubmed: 16148964
BMJ. 2000 Mar 18;320(7237):741-4
pubmed: 10720355
Arch Intern Med. 2008 Mar 10;168(5):493-500
pubmed: 18332295
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
N Engl J Med. 1993 Mar 4;328(9):621-7
pubmed: 8429854
Jt Comm J Qual Improv. 1995 Oct;21(10):541-8
pubmed: 8556111
Med Care. 2016 Dec;54(12):1105-1111
pubmed: 27116111
Health Serv Res. 2009 Apr;44(2 Pt 2):646-64
pubmed: 21456108
Ann Intern Med. 2017 Mar 7;166(5):324-331
pubmed: 28024302
Med Care. 2000 Aug;38(8):785-95
pubmed: 10929991
N Engl J Med. 2010 Nov 18;363(21):1985-8
pubmed: 21047217
JAMA. 2001 Jul 25;286(4):415-20
pubmed: 11466119
Health Serv Res. 2017 Apr;52(2):849-862
pubmed: 27140721
N Engl J Med. 1991 Feb 7;324(6):377-84
pubmed: 1824793
Crit Care Med. 2013 Feb;41(2):389-98
pubmed: 23263619
Inquiry. 1999 Fall;36(3):255-64
pubmed: 10570659
J Am Coll Surg. 2006 Dec;203(6):865-77
pubmed: 17116555
Health Aff (Millwood). 2011 Apr;30(4):581-9
pubmed: 21471476
Emerg Infect Dis. 2001 Mar-Apr;7(2):268-71
pubmed: 11294721
N Engl J Med. 2014 Jan 23;370(4):341-51
pubmed: 24450892
JAMA. 2006 Jan 18;295(3):324-7
pubmed: 16418469
N Engl J Med. 2000 Apr 13;342(15):1123-5
pubmed: 10760315
Int J Qual Health Care. 2016 Dec 1;28(6):640-649
pubmed: 27664822